DexCom is trading at $86.92, up 4.14%, in a move that appears consistent with healthcare-sector strength as investors rotate toward defensive stocks amid inflation concerns.
- No clear company-specific announcement on October 15 explains the move.
- DexCom’s Q3 earnings call is scheduled for October 29.
- Mizuho raised its price target to $100 from $95 on October 13; this earlier action is not a confirmed catalyst for this morning’s move.